Researchers at the University of California, Davis, have developed an investigational brain-computer interface that holds promise for restoring the voices of people who have lost the ability to speak due to neurological conditions.

First-in-class gene therapy moves toward clinical trials to address a life-threatening genetic heart condition with high unmet need

Johnson & Johnson MedTech (NYSE: JNJ)+
today announced the U.S. launch of its Ethicon 4000 surgical stapler.

Smith+Nephew (NYSE: SNN)+
this week announced it launched a new medial stabilized insert for its Legion Total Knee System (TKS).

SUNNYVALE, Calif., June 10, 2025 /PRNewswire/ — In a major milestone for heart failure treatment, the first commercial patients in the U.S. have been successfully implanted with the FDA-approved WiSE® System—marking the beginning of a new chapter in leadless left ventricular endocardial pacing (LVEP) for the treatment of heart failure.

In a study published in PNAS Nexus, Noriyasu Hashida and colleagues designed a test that confirms the presence of live virus by pushing particles through a nanopore, one at a time, and measuring their electrical conductivity, which varies with size and surface charge as well as the unique molecular structure of the virus.

New digital twin technology that allows a University of Virginia-developed artificial pancreas system to adapt to users’ changing needs—and lets users adjust the settings—has been shown to improve type 1 diabetes control, according to a study published in npj Digital Medicine.

Breakthrough Non-Invasive Therapy Installed with Support from Li Ka Shing Foundation to Advance Research and Patient Care